Clinical, Epidemiological, and Oral-Related Factors in Post-COVID-19 Mucormycosis Patients: A Systematic Review of Case Reports
Salvato in:
| Autori: | , , , , , |
|---|---|
| Natura: | artículo original |
| Status: | Versión publicada |
| Data di pubblicazione: | 2025 |
| Descrizione: | Oral mucormycosis has become a significant concern due to increased cases during the COVID-19 pandemic, potentially linked to corticosteroid-induced immune suppression. This study reviews case reports to identify and describe the clinical and epidemiological factors associated with post-COVID-19 mucormycosis from a dental perspective. A comprehensive search of PubMed, Google Scholar, DOAJ, and NIH Library databases yielded 32 relevant case reports from an initial 180. The average age of patients was 53 years, with 21.9% having a confirmed COVID-19 diagnosis one month prior to mucormycosis diagnosis. Corticosteroid use was reported in 65.6% of cases. Common symptoms included pain (65.6%), swelling (21.9%), and ocular pain (12.5%), with Amphotericin B being the predominant treatment (59.4%). Oral manifestations such as maxillary bone exposure (21.9%) and dental abscesses (31.3%) were noted. This study highlights a potential link between corticosteroids and mucormycosis, despite limitations in report consistency and follow-up data, offering valuable insights for clinical management of post-COVID-19 mucormycosis. |
| Stato: | Portal de Revistas UCR |
| Istituzione: | Universidad de Costa Rica |
| Repositorio: | Portal de Revistas UCR |
| Lingua: | Inglés |
| OAI Identifier: | oai:portal.revistas.ucr.ac.cr:article/2214 |
| Accesso online: | https://revistas.ucr.ac.cr/index.php/rOdontos/article/view/2214 |
| Keyword: | Mucormycosis; Case reports; COVID 19; Oral medicine; Systematic review; Oral health. Mucormicosis; Reportes de casos; COVID-19; Medicina oral; Revisión sistemática; Salud bucal. |